Cargando…
Gut microbiota in coronary artery disease: a friend or foe?
There is a growing interest in the role of gut microbiota in the pathophysiology of several diseases, including coronary artery diseases (CAD). Gut microorganisms may produce beneficial effects in myocardial ischemia either directly in the form of exogenous administration or indirectly by acting on...
Autores principales: | Zhang, Bo, Wang, Xinxin, Xia, Ran, Li, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225411/ https://www.ncbi.nlm.nih.gov/pubmed/32352513 http://dx.doi.org/10.1042/BSR20200454 |
Ejemplares similares
-
The roles of ANRIL polymorphisms in coronary artery disease: a meta-analysis
por: Hu, Lina, et al.
Publicado: (2019) -
Association between polymorphisms in interleukin-18 promoter and risk of coronary artery disease: a meta-analysis
por: Lian, Zheng, et al.
Publicado: (2019) -
Association between plasma betaine levels and dysglycemia in patients with coronary artery disease
por: Guo, Fei, et al.
Publicado: (2020) -
Association between ALMS 1 variants and early-onset coronary artery disease: a case–control study in Chinese population
por: Zhang, Shao-Yan, et al.
Publicado: (2020) -
Identification of differentially expressed genes and the role of PDK4 in CD14(+) monocytes of coronary artery disease
por: Du, Pei, et al.
Publicado: (2021)